{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:38:36Z","timestamp":1790221116180,"version":"4.1.0"},"reference-count":115,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"DOI":"10.3389\/fnagi.2020.00255","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T04:15:31Z","timestamp":1597292131000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":79,"title":["Nicotinamide, a Poly [ADP-Ribose] Polymerase 1 (PARP-1) Inhibitor, as an Adjunctive Therapy for the Treatment of Alzheimer\u2019s Disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Felipe","family":"Salech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela P.","family":"Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea C.","family":"Paula-Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol D.","family":"SanMartin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda I.","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1007\/s11064-012-0895-x","article-title":"Activation of PARP by oxidative stress induced by \u03b2-amyloid: implications for Alzheimer\u2019s disease.","volume":"37","author":"Abeti","year":"2012","journal-title":"Neurochem. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1212\/wnl.54.3.588","article-title":"A randomized controlled trial of prednisone in Alzheimer\u2019s disease. Alzheimer\u2019s disease cooperative study.","volume":"54","author":"Aisen","year":"2000","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.21.2819","article-title":"Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression.","volume":"289","author":"Aisen","year":"2003","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1002\/jnr.21479","article-title":"Differences among cell types in NAD+ compartmentalization: a comparison of neurons, astrocytes, and cardiac myocytes.","volume":"85","author":"Alano","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/glia.23265","article-title":"A critical role of TRPM2 channel in A\u03b242-induced microglial activation and generation of tumor necrosis factor-\u03b1.","volume":"66","author":"Alawieyah Syed Mortadza","year":"2018","journal-title":"Glia"},{"key":"B6","year":"2020","journal-title":"Dementia Statistics."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1042\/BST20140153","article-title":"Interaction of neurons and astrocytes underlies the mechanism of A\u03b2-induced neurotoxicity.","volume":"42","author":"Angelova","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"B8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.tem.2014.11.003","article-title":"Poly(ADP-ribose) polymerases as modulators of mitochondrial activity.","volume":"26","author":"Bai","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.1252945","article-title":"Aging-induced type I interferon response at the choroid plexus negatively affects brain function.","volume":"346","author":"Baruch","year":"2014","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nm.4022","article-title":"PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer\u2019s disease.","volume":"22","author":"Baruch","year":"2016","journal-title":"Nat. Med."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8967","article-title":"Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer\u2019s disease pathology.","volume":"6","author":"Baruch","year":"2015","journal-title":"Nat. Commun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms11483","article-title":"Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer\u2019s disease.","volume":"7","author":"Beck","year":"2016","journal-title":"Nat. Commun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/gerona\/glr258","article-title":"Inverse susceptibility to oxidative death of lymphocytes obtained from Alzheimer\u2019s patients and skin cancer survivors: increased apoptosis in Alzheimer\u2019s and reduced necrosis in cancer.","volume":"67","author":"Behrens","year":"2012","journal-title":"J. Gerontol. A. Biol. Sci. Med. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/gerona\/glr039","article-title":"Age-dependent increases in apoptosis\/necrosis ratios in human lymphocytes exposed to oxidative stress.","author":"Behrens","year":"2011","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.tibs.2004.01.007","article-title":"The new life of a centenarian: signalling functions of NAD(P).","volume":"29","author":"Berger","year":"2004","journal-title":"Trends Biochem. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nn.3435","article-title":"CD33 Alzheimer\u2019s disease locus: altered monocyte function and amyloid biology.","volume":"16","author":"Bradshaw","year":"2013","journal-title":"Nat. Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/ars.2017.7269","article-title":"Role of nicotinamide adenine dinucleotide and related precursors as therapeutic targets for age-related degenerative diseases: rationale. Biochemistry, Pharmacokinetics, and Outcomes.","volume":"30","author":"Braidy","year":"2019","journal-title":"Antioxid. Redox Signal"},{"key":"B18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jalz.2010.12.014","article-title":"Extended results of the Alzheimer\u2019s disease anti-inflammatory prevention trial.","volume":"7","author":"Breitner","year":"2011","journal-title":"Alzheimer\u2019s Dement."},{"key":"B19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.freeradbiomed.2016.02.024","article-title":"Mitochondrial poly(ADP-ribose) polymerase: the wizard of Oz at work.","volume":"100","author":"Brunyanszki","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nn.4608","article-title":"Necroptosis activation in Alzheimer\u2019s disease.","volume":"20","author":"Caccamo","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00659","article-title":"Alzheimer disease pathogenesis: insights from molecular and cellular biology studies of oligomeric A\u03b2 and tau species.","volume":"13","author":"Chen","year":"2019","journal-title":"Front. Neurosci."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2020.112555","article-title":"Differential navigational strategies during spatial learning in a new modified version of the Oasis maze.","volume":"385","author":"Concha-Miranda","year":"2020","journal-title":"Behav Brain Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2003.09.072","article-title":"The PARP inhibitor benzamide protects against kainate and NMDA but not AMPA lesioning of the mouse striatum in vivo.","volume":"996","author":"Cosi","year":"2004","journal-title":"Brain Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.trci.2018.04.008","article-title":"The price of progress: funding and financing Alzheimer\u2019s disease drug development.","volume":"4","author":"Cummings","year":"2018","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"B25","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1146\/annurev-pharmtox-010716-105001","article-title":"Mitochondrial mechanisms of neuronal cell death: potential therapeutics.","volume":"57","author":"Dawson","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"18670","DOI":"10.1073\/pnas.1006586107","article-title":"Early deficits in synaptic mitochondria in an Alzheimer\u2019s disease mouse model.","volume":"107","author":"Du","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1111\/bph.12416","article-title":"Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities.","volume":"171","author":"Fatokun","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s40473-019-00179-0","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease and progress in mitochondria-targeted therapeutics.","volume":"6","author":"Flannery","year":"2019","journal-title":"Curr. Behav. Neurosci. Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3233\/JAD-2011-101014","article-title":"Microglia demonstrate age-dependent interaction with amyloid-\u03b2 fibrils.","volume":"25","author":"Floden","year":"2011","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1177\/1178646918776658","article-title":"The Influence of Nicotinamide on Health and Disease in the Central Nervous System.","volume":"11","author":"Fricker","year":"2018","journal-title":"Int. J. Tryptophan Res."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082767","article-title":"Mitochondrial protection by parp inhibition.","volume":"21","author":"Gallyas","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0304-3940(97)00536-3","article-title":"Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells.","volume":"231","author":"Gasparini","year":"1997","journal-title":"Neurosci. Lett."},{"key":"B33","doi-asserted-by":"publisher","first-page":"11500","DOI":"10.1523\/JNEUROSCI.3203-08.2008","article-title":"Nicotinamide restores cognition in Alzheimer\u2019s disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau.","volume":"28","author":"Green","year":"2008","journal-title":"J. Neurosci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 Variants in Alzheimer\u2019s Disease.","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3233\/JAD-160702","article-title":"Mitochondrial dysfunction and synaptic transmission failure in Alzheimer\u2019s disease.","volume":"57","author":"Guo","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.3892\/mmr.2017.7203","article-title":"Amyloid \u03b2-42 induces neuronal apoptosis by targeting mitochondria.","volume":"16","author":"Han","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00233","article-title":"Microglia in Alzheimer disease: well-known targets and new opportunities.","volume":"9","author":"Hemonnot","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/ni.3102","article-title":"Innate immunity in Alzheimer\u2019s disease.","volume":"16","author":"Heneka","year":"2015","journal-title":"Nat. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease.","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: the role of inflammation in Alzheimer disease.","volume":"16","author":"Heppner","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00246","article-title":"Nicotinamide mononucleotide: a promising molecule for therapy of diverse diseases by Targeting NAD+ metabolism.","volume":"8","author":"Hong","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease.","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6392763","article-title":"The role of the antioxidant response in mitochondrial dysfunction in degenerative diseases: cross-talk between antioxidant defense, autophagy, and apoptosis.","volume":"2019","author":"Huang","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1056\/NEJMoa010178","article-title":"Nonsteroidal antiinflammatory drugs and the risk of Alzheimer\u2019s disease.","volume":"345","author":"in \u2019t Veld","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.437","article-title":"AIF-independent parthanatos in the pathogenesis of dry age-related macular degeneration.","volume":"8","author":"Jang","year":"2017","journal-title":"Cell Death Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1582-4934.2001.tb00134.x","article-title":"Cell death mechanisms in neurodegeneration.","volume":"5","author":"Jellinger","year":"2001","journal-title":"J. Cell. Mol. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.arr.2017.08.005","article-title":"The role of the immune system in Alzheimer disease: etiology and treatment.","volume":"40","author":"Jevtic","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer\u2019s disease.","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2020.129669","article-title":"Role of PARP-1 in mitochondrial homeostasis.","volume":"1864","author":"Kadam","year":"2020","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-152","article-title":"Poly(ADP-ribose)polymerase-1 modulates microglial responses to amyloid \u03b2.","volume":"8","author":"Kauppinen","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.4049\/jimmunol.174.4.2288","article-title":"Poly(ADP-Ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death.","volume":"174","author":"Kauppinen","year":"2005","journal-title":"J. Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s10571-016-0434-4","article-title":"Relationship between \u03b2-amyloid and mitochondrial dynamics.","volume":"37","author":"Kim","year":"2017","journal-title":"Cell. Mol. Neurobiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/nn.3500","article-title":"Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss.","volume":"16","author":"Lee","year":"2013","journal-title":"Nat. Neurosci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1089\/ars.2011.4173","article-title":"Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation.","volume":"16","author":"Leuner","year":"2012","journal-title":"Antioxidants Redox Signal."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-0270-1","article-title":"Multiple molecular mechanisms form a positive feedback loop driving amyloid \u03b242 peptide-induced neurotoxicity via activation of the TRPM2 channel in hippocampal neurons article.","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.neurobiolaging.2012.11.020","article-title":"Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession.","volume":"34","author":"Liu","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"B58","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/brain\/122.2.247","article-title":"Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer\u2019s disease.","volume":"122","author":"Love","year":"1999","journal-title":"Brain"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107755","article-title":"Poly(ADP-ribose) polymerase-1 inhibits mitochondrial respiration by suppressing PGC-1\u03b1 activity in neurons.","volume":"160","author":"Lu","year":"2019","journal-title":"Neuropharmacology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.1073\/pnas.96.10.5774","article-title":"Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism.","volume":"96","author":"Mandir","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B61","doi-asserted-by":"publisher","first-page":"E1316","DOI":"10.1073\/pnas.1525466113","article-title":"The adaptive immune system restrains Alzheimer\u2019s disease pathogenesis by modulating microglial function.","volume":"113","author":"Marsh","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B62","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/brb3.239","article-title":"PARP1 enhances inflammatory cytokine expression by alteration of promoter chromatin structure in microglia.","volume":"4","author":"Mart\u00ednez-Zamudio","year":"2014","journal-title":"Brain Behav."},{"key":"B63","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3233\/JAD-151040","article-title":"Bioenergetic impairment in animal and cellular models of Alzheimer\u2019s disease: PARP-1 inhibition rescues metabolic dysfunctions.","volume":"54","author":"Martire","year":"2016","journal-title":"J. Alzheimers. Dis."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072169","article-title":"PARP-1 modulates amyloid beta peptide-induced neuronal damage.","volume":"8","author":"Martire","year":"2013","journal-title":"PLoS One"},{"key":"B65","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mad.2015.04.001","article-title":"PARP-1 involvement in neurodegeneration: a focus on Alzheimer\u2019s and Parkinson\u2019s diseases.","volume":"14","author":"Martire","year":"2015","journal-title":"Mech. Ageing Dev."},{"key":"B66","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0197-4580(00)00112-3","article-title":"A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients.","volume":"21","author":"Maurer","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212540","article-title":"Advances in the use of PARP inhibitor therapy for breast cancer.","volume":"7","author":"McCann","year":"2018","journal-title":"Drugs Context"},{"key":"B68","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/s0531-5565(98)00013-8","article-title":"The importance of inflammatory mechanisms in Alzheimer disease.","volume":"33","author":"McGeer","year":"1998","journal-title":"Exp. Gerontol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"E2070","DOI":"10.1212\/WNL.0000000000007232","article-title":"A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.","volume":"92","author":"Meyer","year":"2019","journal-title":"Neurology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00232-005-0839-3","article-title":"The role of TRP channels in oxidative stress-induced cell death.","volume":"209","author":"Miller","year":"2006","journal-title":"J. Membr. Biol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1161\/01.str.31.7.1679","article-title":"Delayed treatment with nicotinamide (Vitamin B(3)) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rats.","volume":"31","author":"Mokudai","year":"2000","journal-title":"Stroke"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00399","article-title":"N-Acetylcysteine Prevents the Spatial Memory Deficits and the Redox-Dependent RyR2 Decrease Displayed by an Alzheimer\u2019s Disease Rat Model.","volume":"10","author":"More","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.bbadis.2014.04.012","article-title":"Is Alzheimer\u2019s disease a systemic disease?","volume":"1842","author":"Morris","year":"2014","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B74","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.semcdb.2016.11.007","article-title":"Poly(ADP-ribose)polymerase-1 hyperactivation in neurodegenerative diseases: the death knell tolls for neurons.","volume":"63","author":"Narne","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00140","article-title":"Microglia in Alzheimer\u2019s disease: activated, dysfunctional or degenerative.","volume":"10","author":"Navarro","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"15157","DOI":"10.1523\/JNEUROSCI.4081-14.2015","article-title":"The transient receptor potential melastatin 2 (TRPM2) channel contributes to \u03b2-amyloid oligomer-related neurotoxicity and memory impairment.","volume":"35","author":"Ostapchenko","year":"2015","journal-title":"J. Neurosci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.dnarep.2018.08.022","article-title":"The comings and goings of PARP-1 in response to DNA damage.","volume":"71","author":"Pascal","year":"2018","journal-title":"DNA Repair."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1089\/ars.2010.3287","article-title":"Amyloid \u03b2-peptide oligomers stimulate RyR-mediated Ca 2+ release inducing mitochondrial fragmentation in hippocampal neurons and prevent RyR-mediated dendritic spine remodeling produced by BDNF.","volume":"14","author":"Paula-Lima","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"B79","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.redox.2018.09.001","article-title":"Mitochondrial permeability transition pore contributes to mitochondrial dysfunction in fibroblasts of patients with sporadic Alzheimer\u2019s disease.","volume":"19","author":"P\u00e9rez","year":"2018","journal-title":"Redox Biol."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00553","article-title":"Mitochondrial bioenergetics is altered in fibroblasts from patients with sporadic Alzheimer\u2019s disease.","volume":"11","author":"P\u00e9rez","year":"2017","journal-title":"Front. Neurosci."},{"key":"B81","doi-asserted-by":"crossref","first-page":"892","DOI":"10.2174\/1567205011666141001113135","article-title":"Increased susceptibility to oxidative death of lymphocytes from Alzheimer patients correlates with dementia severity.","volume":"11","author":"Ponce","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nn.4475","article-title":"The role of peripheral immune cells in the CNS in steady state and disease.","volume":"20","author":"Prinz","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/glia.23790","article-title":"Microglial NMDA receptors drive pro-inflammatory responses via PARP-1\/TRMP2 signaling.","volume":"68","author":"Raghunatha","year":"2020","journal-title":"Glia"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4383258","article-title":"Evidence for decreased nucleolar PARP-1 as an early marker of cognitive impairment.","volume":"2019","author":"Regier","year":"2019","journal-title":"Neural Plast."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer\u2019s disease.","volume":"348","author":"Reisberg","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"31616","DOI":"10.1074\/jbc.M109.025882","article-title":"Mitochondrial localization of PARP-1 requires interaction with mitofilin and is involved in the maintenance of mitochondrial DNA integrity.","volume":"284","author":"Rossi","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00310","article-title":"PARP-1 and p53 regulate the increased susceptibility to oxidative death of lymphocytes from MCI and AD patients.","volume":"9","author":"Salech","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00058","article-title":"Cancer imprints an increased PARP-1 and p53-dependent resistance to oxidative stress on lymphocytes of patients that later develop Alzheimer\u2019s disease.","volume":"12","author":"Salech","year":"2018","journal-title":"Front. Neurosci."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2014.00013","article-title":"Ryanodine receptor-mediated Ca2+ release underlies iron-induced mitochondrial fission and stimulates mitochondrial Ca2+ uptake in primary hippocampal neurons.","volume":"7","author":"SanMart\u00edn","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00115","article-title":"RyR2-mediated Ca2+ release and mitochondrial ROS generation partake in the synaptic dysfunction caused by amyloid \u03b2 peptide oligomers.","volume":"10","author":"Sanmart\u00edn","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-016-0088-1","article-title":"The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer\u2019s disease.","volume":"11","author":"Saresella","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"B92","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1126\/science.aai8231","article-title":"Can immunotherapy treat neurodegeneration?","volume":"357","author":"Schwartz","year":"2017","journal-title":"Science"},{"key":"B93","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years.","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01172","article-title":"Poly(ADP-ribose)polymerase-1 in lung inflammatory disorders: a review.","volume":"8","author":"Sethi","year":"2017","journal-title":"Front. Immunol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s11011-018-0297-0","article-title":"Nicotinamide reverses behavioral impairments and provides neuroprotection in 3?nitropropionic acid induced animal model ofHuntington\u2019s disease: implication of oxidative stress? poly(ADP? ribose) polymerase pathway.","volume":"33","author":"Sidhu","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"B96","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/bf00971360","article-title":"Niacinamide transport through the blood-brain barrier.","volume":"12","author":"Spector","year":"1987","journal-title":"Neurochem. Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/ca.980080612","article-title":"An english translation of alzheimer\u2019s 1907 paper, \u00fcber eine eigenartige erkankung der hirnrinde?","volume":"8","author":"Stelzmann","year":"1995","journal-title":"Clin. Anat."},{"key":"B98","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1089\/neu.2013.3194","article-title":"PARP-1 inhibition attenuates neuronal loss, microglia activation and neurological deficits after traumatic brain injury.","volume":"31","author":"Stoica","year":"2014","journal-title":"J. Neurotrauma"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3233\/JAD-170585","article-title":"Mitochondria and mitochondrial cascades in Alzheimer\u2019s disease.","volume":"62","author":"Swerdlow","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B100","doi-asserted-by":"publisher","first-page":"13161","DOI":"10.1093\/nar\/gku1089","article-title":"Opposing roles of mitochondrial and nuclear PARP1 in the regulation of mitochondrial and nuclear DNA integrity: implications for the regulation of mitochondrial function.","volume":"42","author":"Szczesny","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"B101","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3109\/09540261.2013.849663","article-title":"The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer\u2019s disease and its progression after onset.","volume":"25","author":"Tschanz","year":"2013","journal-title":"Int. Rev. Psychiatry"},{"key":"B102","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3109\/10715762.2013.857018","article-title":"Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in A\u03b2(1-42)-induced rat model of Alzheimer\u2019s disease.","volume":"48","author":"Turunc Bayrakdar","year":"2014","journal-title":"Free Radic. Res."},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-019-0551-7","article-title":"Systemic and central nervous system metabolic alterations in Alzheimer\u2019s disease.","volume":"11","author":"Van Der Velpen","year":"2019","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.aac4854","article-title":"NAD+ in aging, metabolism, and neurodegeneration.","volume":"350","author":"Verdin","year":"2015","journal-title":"Science"},{"key":"B105","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.coph.2015.09.011","article-title":"Astroglia dynamics in ageing and Alzheimer\u2019s disease.","volume":"26","author":"Verkhratsky","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"17763","DOI":"10.1073\/pnas.1010461107","article-title":"Spatial correlation between brain aerobic glycolysis and amyloid-\u03b2 (A\u03b2) deposition.","volume":"107","author":"Vlassenko","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B107","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.bbr.2011.06.009","article-title":"Continuous nicotinamide administration improves behavioral recovery and reduces lesion size following bilateral frontal controlled cortical impact injury.","volume":"224","author":"Vonder Haar","year":"2011","journal-title":"Behav. Brain Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2016.04.060","article-title":"Nicotinamide mononucleotide protects against \u03b2-amyloid oligomer-induced cognitive impairment and neuronal death.","volume":"1643","author":"Wang","year":"2016","journal-title":"Brain Res."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease.","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B110","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.expneurol.2009.03.020","article-title":"Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos.","volume":"218","author":"Wang","year":"2009","journal-title":"Exp. Neurol."},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2000902","article-title":"Poly(ADP-Ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (Parthanatos).","volume":"4","author":"Wang","year":"2011","journal-title":"Sci. Signal."},{"key":"B112","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s007020050098","article-title":"The effects of perturbed energy metabolism on the processing of amyloid precursor protein in PC12 cells.","volume":"105","author":"Webster","year":"1998","journal-title":"J. Neural Transm."},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006346","article-title":"Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.","volume":"2","author":"Wyss-Coray","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s00702-009-0311-0","article-title":"Cell-derived soluble oligomers of human amyloid-\u03b2 peptides disturb cellular homeostasis and induce apoptosis in primary hippocampal neurons.","volume":"116","author":"Yang","year":"2009","journal-title":"J. Neural Transm."},{"key":"B115","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neulet.2017.03.027","article-title":"Nicotinamide mononucleotide inhibits JNK activation to reverse Alzheimer disease.","volume":"647","author":"Yao","year":"2017","journal-title":"Neurosci. Lett."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2020.00255\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T04:15:36Z","timestamp":1597292136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2020.00255\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":115,"alternative-id":["10.3389\/fnagi.2020.00255"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2020.00255","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]},"article-number":"255"}}